01/06/2025 | Press release | Distributed by Public on 01/06/2025 15:05
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective January 1, 2025, Suneel Gupta, Ph.D., Protagonist Therapeutics, Inc.'s Chief Development Officer, transitioned to Executive Vice President, Clinical Development.